Infection with parvovirus B19 and the maternal, mirror syndrome: A case report

Patrizia Rölli1, Lisa Vifian1, Stefano de Marchi1

  • 1From the Department of Anaesthesiology and Pain Medicine (PR, LV, CV), Department of Cardiology (SDM) and Department of Obstetrics and Gynecology, Inselspital, University Hospital, University of Bern, Bern, Switzerland (LR).

In 2024, an extreme increase in the number of parvovirus B19 (B19V) infections occurred worldwide, including in the pregnant population, resulting in severe foetal morbidity and mortality. We describe the case of a 37-year-old patient (G2/P1) who was 26 weeks 0 days pregnant at admission and who presented with foetal hydrops and mirror syndrome due to B19V infection and sudden onset of acute perimyocarditis in the mother, possibly triggered by the foetal situation and severe anaemia. Foetal hydrops is a life-threatening manifestation of foetal infection with B19V. Independent of whether it is immune or nonimmune, hydrops fetal is occurs in 1 : 1500 to 4000 pregnancies. In 6.1% of foetal hydrops cases, the hydrops mirrors the symptoms between the mother and the child. Mirror syndrome was defined as foetal hydrops and/or placentomegaly associated with the maternal development of pronounced oedema with or without preeclampsia symptoms. Due to the increase in infections and the potentially foetal consequences for the unborn child, the possible therapy, which requires well coordinated multidisciplinary cooperation, is relevant for anaesthesiologists as demonstrated in the following case. The patient underwent two foetal transfusions and one foetal ascites puncture; consequently, she required anaesthesiological care on multiple occasions. We emphasise the importance of ensuring that patients with this condition are closely monitored, not only by the obstetrician but also by the anaesthesiologist, so that the clinical deterioration of the mother and/or the child can be quickly recognised and treated appropriately.

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
58.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
448